Greenhaven Road Investment Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.4M Sell
1,260,039
-275,212
-18% -$3.64M 11.94% 2
2026
Q1
$21.2M Sell
1,535,251
-64,686
-4% -$975K 14.55% 2
2025
Q4
$28.8M Sell
1,599,937
-53,110
-3% -$954K 4.86% 5
2025
Q3
$30.6M Buy
1,653,047
+135,000
+9% +$2.12M 4.52% 5
2025
Q2
$24.3M Sell
1,518,047
-54,046
-3% -$963K 8.32% 4
2025
Q1
$30.5M Sell
1,572,093
-403,448
-20% -$8.49M 12.45% 2
2024
Q4
$43.5M Sell
1,975,541
-110,870
-5% -$2.13M 6.96% 3
2024
Q3
$35.1M Sell
2,086,411
-378,634
-15% -$5.62M 14.95% 3
2024
Q2
$29.5M Sell
2,465,045
-170,175
-6% -$1.9M 13.65% 3
2024
Q1
$29.2M Sell
2,635,220
-223,048
-8% -$2.28M 12.37% 3
2023
Q4
$24.8M Sell
2,858,268
-314,339
-10% -$2.44M 10.4% 3
2023
Q3
$24.3M Sell
3,172,607
-356,569
-10% -$2.68M 12.18% 3
2023
Q2
$25.4M Buy
3,529,176
+6,218
+0.2% +$36.3K 12.87% 3
2023
Q1
$21.5M Sell
3,522,958
-56,256
-2% -$305K 12.31% 3
2022
Q4
$15.6M Buy
3,579,214
+106,838
+3% +$477K 10.07% 3
2022
Q3
$13.6M Buy
3,472,376
+402,507
+13% +$2.02M 8.18% 5
2022
Q2
$15.7M Buy
3,069,869
+1,069,869
+53% +$5.57M 8.04% 5
2022
Q1
$12.8M Buy
2,000,000
+821,364
+70% +$5.45M 4.18% 6
2021
Q4
$9.45M Buy
+1,178,636
New +$11.1M 2.13% 12

Other funds holding CLBT

Greenhaven Road Investment Management's CLBT Position: Q2 2026 in Review

Greenhaven Road Investment Management reduced its Cellebrite (CLBT) stake by 18% in Q2 2026, selling an estimated $3.64M and leaving 1,260,039 shares worth $18.4M. The position accounts for 11.94% of the portfolio, ranked #2.

Greenhaven Road Investment Management first reported a position in CLBT in Q4 2021 and has held it in 19 quarters since. The position peaked at $43.5M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Greenhaven Road Investment Management held 1,260,039 shares of Cellebrite worth $18.4M as of Q2 2026.
  • Greenhaven Road Investment Management sold 275,212 Cellebrite shares in Q2 2026, an estimated $3.64M.
  • Cellebrite made up 11.94% of Greenhaven Road Investment Management's portfolio in Q2 2026, its #2 holding.
  • Greenhaven Road Investment Management first reported a position in Cellebrite in Q4 2021 and has held it in 19 quarters since.
  • Greenhaven Road Investment Management's Cellebrite position peaked at $43.5M in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Greenhaven Road Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.